Diabetes pill Avandia to be severely restricted
U.S. government health regulators will allow GlaxoSmithKline to continue selling a controversial diabetes pill but will restrict access to the once-blockbuster drug because of heart attack risks.
FDA reviewing safety of Actos diabetes drug
The Food and Drug Administration said on Friday it was reviewing if Takeda Pharmaceutical Co Ltd’s blockbuster diabetes drug Actos may be linked to bladder cancer.
Proposed diabetes test misses most cases: study
NEW YORK (Reuters Health) – A new proposed diabetes test could miss millions of cases of diabetes and pre-diabetes and also over-diagnose black Americans if it was used as a screening tool, suggests a new study.